secwatch / observer
8-K filed March 19, 2024, 7:59 PM ET CIK 0001689923
M&A confidence high sentiment neutral materiality 1.00

Alteryx, Inc.: M&A transaction — Alteryx acquired by Clearlake and Insight for $48.25/share; stock delisted

Alteryx, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles R. Cory

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Eileen M. Schloss

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Dean A. Stoecker

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Anjali Joshi

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Timothy I. Maudlin

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

CeCe Morken

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Dan Warmenhoven

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Jeffrey L. Horing

Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Appointed

Behdad Eghbali

Sole Director
Alteryx, Inc.
Effective
2024-03-19
Filed
March 19, 2024, 7:59 PM ET
At the Effective Time, Behdad Eghbali became the sole director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles R. Cory departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Eileen M. Schloss departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dean A. Stoecker departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Anjali Joshi departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy I. Maudlin departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

CeCe Morken departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dan Warmenhoven departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey L. Horing departed as Director at Alteryx, Inc..

Action
ceased to be
Role
Director
Exact text from the filing
Dean A. Stoecker, Charles R. Cory, Jeffrey L. Horing, Anjali Joshi, Timothy I. Maudlin, CeCe Morken, Eileen M. Schloss and Dan Warmenhoven, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Behdad Eghbali was appointed as Sole Director at Alteryx, Inc..

Action
became
Role
Sole Director
Exact text from the filing
At the Effective Time, Behdad Eghbali became the sole director of the Company.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.7

Alteryx, Inc.: Shareholders' rights ceased upon conversion of shares to cash per merger.

Exact text from the filing
Pursuant to the Merger Agreement and in connection with the consummation of the Merger, each outstanding share of Common Stock that was issued and outstanding immediately prior to the Effective Time (except as described in Item 2.01) was converted into the right to receive the Per Share Price.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Alteryx, Inc.: The certificate of incorporation was amended and restated in connection with the merger.

Change
charter amendment
Exact text from the filing
Effective upon completion of the Merger, the certificate of incorporation of the Company, as in effect immediately prior to the Merger, was amended and restated to be in the form of the certificate of incorporation attached as Exhibit 3.1.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Alteryx, Inc.: The bylaws were amended and restated in connection with the merger.

Change
bylaw amendment
Exact text from the filing
Effective upon completion of the Merger, the bylaws of the Company, as in effect immediately prior to the Merger, were amended and restated to be in the form of the bylaws attached as Exhibit 3.2.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 1.0

Alteryx, Inc. underwent a change of control involving Azurite Intermediate Holdings, a Delaware corporation for $48.25 per share of Class A common stock, par value $0.0001 per share (closed 2024-03-19).

Action
change of control
Counterparty
Azurite Intermediate Holdings, a Delaware corporation
Consideration
$48.25 per share of Class A common stock, par value $0.0001 per share
Closing
2024-03-19
Exact text from the filing
Introductory Note This Current Report on Form 8-K is being filed in connection with the completion of the previously announced Merger (as defined below) pursuant to the Agreement and Plan of Merger, dated December 18, 2023 (the “ Merger Agreement ”), among Azurite Intermediate Holdings, a Delaware corporation (“ Parent ”), Azurite Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), and Alteryx, Inc., a Delaware corporation (the “ Company ”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Alteryx, Inc. entered into Credit Agreement with SSLP Lending, LLC valued at Initial term loan facility of $550 million; delayed draw term loan facility up to $1,250 million; re (effective 2024-03-19).

Action
entry
Agreement
credit facility
Counterparty
SSLP Lending, LLC
Value
Initial term loan facility of $550 million; delayed draw term loan facility up to $1,250 million; re
Effective
2024-03-19
Exact text from the filing
Parent entered into that certain Credit Agreement with Azurite Software Intermediate Holdings, Inc., a Delaware corporation and the sole stockholder of Parent (“ Holdings ”), SSLP Lending, LLC, as administrative agent and collateral agent, and the lenders and letter of credit issuers from time to time party thereto (the “ Credit Agreement ”), which provides for (i) an initial term loan facility in an aggregate principal amount equal to $550 million, (ii) a delayed draw term loan facility in an aggregate principal amount of up to $1,250 million, and (iii) a revolving loan facility in an aggregate principal amount of up to $200 million.
View on SEC.gov

236 governance changes filed in the last 30 days. Browse all governance changes →

Source: SEC EDGAR
accession 0001193125-24-070837
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.